FDA issues warning to C Change Surgical

11/6/2008 | FDAnews

The FDA has sent a warning letter to C Change Surgical saying that it did not secure pre-market approval prior to marketing its IntraTemp solution warmer. The company has resolved the FDA's concerns and is seeking a follow-up review of the device, CEO Patrick Kammer said.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD